Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dentsply Sirona Inc (NQ: XRAY )

18.70 +0.18 (+1.00%)
Streaming Delayed Price Updated: 3:05 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 783,241
Open 18.50
Bid (Size) 18.70 (11)
Ask (Size) 18.71 (8)
Prev. Close 18.52
Today's Range 18.32 - 18.79
52wk Range 17.21 - 37.60
Shares Outstanding 198,800,000
Dividend Yield 2.99%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NASDAQ: XRAY Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages DENTSPLY SIRONA Inc. (NASDAQ: XRAY) Investors with Significant Losses to Contact the Firm
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
Crude Oil Rises 1%; US Jobless Claims Increase To 221,000
Via Benzinga
Exposures Fossil Fuels

Performance

YTD
-47.50%
-47.50%
1 Month
-23.43%
-23.43%
3 Month
-23.93%
-23.93%
6 Month
-33.32%
-33.32%
1 Year
-39.64%
-39.64%

More News

Read More
Gold Gains 1%; Halliburton Posts Weak Q3 Results
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
The Latest Analyst Ratings For Dentsply Sirona
Via Benzinga
Navigating 6 Analyst Ratings For Dentsply Sirona
Via Benzinga
Analyst Expectations For Dentsply Sirona's Future
Via Benzinga
Dentsply Sirona Stock Sinks On Dismal 2024 Guidance, Blames Macroeconomic, Competitive Pressures And Weakened Demand
Via Benzinga
Topics Earnings
Exposures Financial
Tesla To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Critical Insights From Dentsply Sirona Analyst Ratings: What You Need To Know
Via Benzinga
Dentsply Sirona Misses Q2 Targets - Plans Restructuring Plan Amid Weak Demand
Via Benzinga
XRAY Stock Earnings: Dentsply Sirona Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
A Glimpse Into The Expert Outlook On Dentsply Sirona Through 10 Analysts
Via Benzinga
Evaluating Dentsply Sirona: Insights From 8 Financial Analysts
Via Benzinga
Key Takeaways From Dentsply Sirona Analyst Ratings
Via Benzinga
XRAY Investors Have the Opportunity to Join Investigation of DENTSPLY SIRONA Inc. with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
$4M Bet On This Health Care Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
7 Long-Term Stocks to Buy Now: May 2024
Via InvestorPlace
DENTSPLY INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Dentsply Sirona, Inc. - XRAY
From Kahn Swick & Foti, LLC
Via Business Wire
A Glimpse Into The Expert Outlook On Dentsply Sirona Through 4 Analysts
Via Benzinga
Demystifying Dentsply Sirona: Insights From 4 Analyst Reviews
Via Benzinga
Earnings Scheduled For February 29, 2024
Via Benzinga
Nasdaq Gains Over 200 Points; Dentsply Sirona Shares Fall After Q1 Results
Via Benzinga
Dentsply Sirona Falls Over 4% Following Q1 Results - Read Why
Via Benzinga
XRAY Stock Earnings: Dentsply Sirona Meets EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.